🕵️ Amgen Inc ($AMGN)
SEC insider & ownership activity, last 12 months · CIK 318154 · every row links its SEC filing
Over the last 12 months insiders sold $25.6M with no open-market buying against it. Santos Esteban sold $20.8M in discretionary trades (Feb). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 5 sellers, $25.6M (9 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Santos Esteban | 0 | – | 2 | $20.8M | Feb 26, 2026 |
| Gordon Murdo | 0 | – | 1 | $2.3M | Nov 12, 2025 |
| Nancy A. Grygiel | 0 | – | 4 | $1.8M | May 4, 2026 |
| Matthew C. Busch | 0 | – | 1 | $376K | Feb 19, 2026 |
| Khosla Rachna | 0 | – | 1 | $299K | Nov 12, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Blackrock, Inc. | 7.6% | 13G | Apr 17, 2025 | filing ↗ | |
| Vanguard Capital Management | 7.5% | 13G | Apr 29, 2026 | filing ↗ | |
| Capital World Investors | 5.5% | 13G | May 14, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Nancy A. Grygiel | $400K | May 4, 2026 | filing ↗ |
| Santos Esteban | $20.8M | Feb 26, 2026 | filing ↗ |
| Matthew C. Busch | $375K | Feb 19, 2026 | filing ↗ |
| Nancy A. Grygiel | $1.1M | Nov 20, 2025 | filing ↗ |
| Khosla Rachna | $300K | Nov 12, 2025 | filing ↗ |
| Gordon Murdo | $2.3M | Nov 12, 2025 | filing ↗ |
| Nancy A. Grygiel | $373K | Aug 20, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Shareholder vote (5.07) | May 19, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 19, 2026 | filing ↗ |
| Earnings (2.02) | Apr 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 30, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 22, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 17, 2026 | filing ↗ |
| Earnings (2.02) | Feb 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 3, 2026 | filing ↗ |
| Agreement terminated (1.02) | Jan 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 30, 2026 | filing ↗ |
| Earnings (2.02) | Nov 4, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 4, 2025 | filing ↗ |
| Earnings (2.02) | Aug 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 5, 2025 | filing ↗ |